Submitted by Anonymous (not verified) on 14 April 2026 - 11:08
Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 2, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Pavblu, aflibercept, Revision: 2, Status: Authorised